Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The estimated prevalence of bloating is 15 to 30% in the adult US population and is even higher in patients with disorders of gut-brain interaction (DGBIs). Despite this frequency, there is little research into patients who endorse bloating as a predominant symptom. The aim of this study was to better characterize these patients.

Materials And Methods: New patients with DGBIs were asked to identify their 3 most predominant symptoms over the preceding 3 months; those who reported bloating were classified as "bloating predominant." Rome IV and symptom-specific questionnaires were administered to assess for the frequency of DGBIs and other predominant symptoms in this patient population. Using univariable and multivariable modeling, we analyzed the associations between bloating predominance, DGBI subtype, and clinical characteristics.

Results: Of the 586 patients surveyed, 242 (41%) reported predominant bloating. Bloating-predominant patients were more likely to be female, younger, and meet the criteria for IBS-mixed (IBS-M), functional constipation, and functional dyspepsia compared with nonbloating-predominant patients. Bloating-predominant patients were also more likely to endorse concurrently predominant constipation, incomplete evacuation, abdominal pain, belching, and/or nausea. On multivariable logistic regression, constipation and abdominal pain severity were positively associated, although depression was negatively associated with predominant bloating.

Conclusions: Patients with predominant bloating are more likely to have constipation-related symptoms than diarrhea-related symptoms. They are also more likely to have more severe abdominal pain than patients without predominant bloating. These findings help characterize patients with bloating as a predominant symptom and suggest that diagnosing and treating constipation should be considered as first-line treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148919PMC
http://dx.doi.org/10.1097/MCG.0000000000001767DOI Listing

Publication Analysis

Top Keywords

bloating predominant
12
predominant symptom
12
predominant bloating
12
abdominal pain
12
patients
11
predominant
10
bloating
9
patients endorse
8
predominant symptoms
8
bloating-predominant patients
8

Similar Publications

Irritable bowel syndrome (IBS) constitutes a chronic functional gastrointestinal disorder characterized by abdominal pain and irregular bowel habits. Diagnosis typically hinges upon symptomatology, following the exclusion of organic pathologies such as intestinal inflammation and malignancies. IBS manifests with diverse symptoms attributable to aberrant intestinal function, including diarrhea, constipation, and bloating, stratified into four types based on the predominance of diarrhea versus constipation.

View Article and Find Full Text PDF

Functional disorders of the upper digestive tract, including functional dyspepsia and irritable bowel syndrome with predominant gastric symptoms, represent conditions that are highly prevalent in the general population and are associated with a marked impairment of patients' quality of life. Functional dyspepsia, characterised by symptoms such as epigastric pain, early satiety and bloating, in the absence of detectable structural abnormalities, is commonly divided into two subtypes: postprandial distress syndrome and epigastric pain syndrome, as described in the Rome IV diagnostic criteria. Although the pathogenesis of these disorders is not completely understood, it is believed that there is a complex interaction between altered gastrointestinal motility, visceral hypersensitivity, gut dysbiosis and dysfunction in the central modulation of visceral signals.

View Article and Find Full Text PDF

Background The intestinal-gas symptoms of irritable bowel syndrome (IBS) are particularly bothersome and refractory. In our Japanese clinical practice, we often experience IBS patients with severe complaints of excess 'flatulence' or 'rumbling' as well as bloating, and have considerable difficulty in treating them. However, few studies have been reported on this subgroup of IBS for whom intestinal-gas symptom is the most bothersome ).

View Article and Find Full Text PDF

Despite the complexity of the gut microbiome, several scores that use taxonomic characteristics exist that attempt to identify a healthy gut or gastrointestinal disease. Two systems in use are the metagenomic aerotolerant predominance index (MAPI) and keystone scores. The aim of this analysis was to compare different gut microbiome scores, specifically MAPI and a keystone species score, on two cross-sectional data sets and to investigate correlations of these scores with self-reported gut discomfort and gastrointestinal disease.

View Article and Find Full Text PDF

Identifying the transition from ante-mortem to post-mortem odor in cadavers in an outdoor environment.

Forensic Sci Int Synerg

December 2025

Département de Chimie, Biochimie et Physique, Université Du Québec à Trois-Rivières, Boul. des Forges, 3351, Trois-Rivières, Québec, Canada.

This study investigates the transition from ante-mortem to post-mortem odor in human remains during the early post-mortem period in an outdoor environment. Three cadavers (donors) were placed at an outdoor human decomposition facility, and volatile organic compounds (VOCs) were collected and analyzed using thermal desorption coupled with comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry (TD-GC × GC-TOFMS). The key findings revealed that nitrogen-containing compounds were predominant in early post-mortem VOC profiles, driven by enzymatic and bacterial activity.

View Article and Find Full Text PDF